Long-term Clinical Effectiveness of Ustekinumab in Patients with Crohn’s Disease Who Failed Biologic Therapies: A National Cohort StudyClaire Liefferinckx, Séverine Vermeire, Bram Verstockt et al.|Journal of Crohn s and Colitis|2019Cited by 121
Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction StudyLaurent Peyrin‐Biroulet, Toshimitsu Fujii, Matthew Germinaro et al.|Gastroenterology|2023Cited by 97